University of Galway spinout, Relevium Medical, has been awarded €4.6m in Government funding to develop a treatment for knee osteoarthritis.
Relevium Medical secured the investment for their RestOAre project which is working on developing therapies for debilitating chronic pain and disease progression of knee osteoarthritis.
Work carried out by academics at the university has included innovative pain modelling and drug screening, along with scientific analysis of biomolecules derived from marine organisms which target receptors in the knee.
The funding was awarded through the Disruptive Technologies Innovation Fund (DTIF), which is managed by the Department of Enterprise, Trade and Employment and administered by Enterprise Ireland.
It will support the development of a treatment that offers patients immediate long-lasting pain relief and reduced progression of knee osteoarthritis.
The disease is incurable, complex and progressively worsens over time impacting the whole joint structure.
It is the fastest-growing cause of disability due to an ageing population and the obesity epidemic.
Affecting more people each year than cancer …